<?xml version="1.0" encoding="UTF-8"?>
<p id="para10">Vaccines can be powerful tools for preventing potential outbreaks of epidemic infectious diseases from becoming humanitarian crises.
 <xref rid="bib1" ref-type="bibr">
  <sup>1</sup>
 </xref> Developing these vaccines requires investment.
 <xref rid="bib2" ref-type="bibr">
  <sup>2</sup>
 </xref> However, evidence on what it would cost to successfully develop a sound epidemic infectious disease vaccine portfolio is scarce.
 <xref rid="bib3" ref-type="bibr">
  <sup>3</sup>
 </xref> This is partly because of a paucity of explicit, publicly available cost data. In addition, there is little agreement across global vaccine development funders on which epidemic infectious disease investments should be prioritised, which stems from an absence of global research and development portfolio strategy and coordination.
 <xref rid="bib4" ref-type="bibr">
  <sup>4</sup>
 </xref>
</p>
